AVLN
AVLN
US05348Y1055
Avalyn Pharma Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
91.292.000 57.121.000
59.8%
Operating Income -91.292.000 -57.121.000
59.8%
Pretax Income -85.204.000 -49.744.000
71.3%
Net Income Common Stockholders -85.204.000 -49.744.000
71.3%
-- --
--
-- --
--
ende